James E. Mullally
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
-
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- DNA Repair Mechanisms
Papers in
-
- Ubiquitin and proteasome pathways 6
- Glycosylation and Glycoproteins Research 2
- Oncology 5
- Peptidase Inhibition and Analysis 4
- Cancer-related Molecular Pathways 2
- Co-authors
- F.A. Fitzpatrick (3 shared papers)F.A. Fitzpatrick (2 shared papers)Keith D. Wilkinson (4 shared papers)Kornelia Edes (2 shared papers)Philip J. Moos (2 shared papers)Francisca E. Reyes‐Turcu (1 shared paper)Xiaodong Cheng (1 shared paper)A. Héroux (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Journal of Medicinal Chemistry (1 paper)Molecular Pharmacology (1 paper)Cell (1 paper)Carcinogenesis (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
James E. Mullally
10 papers receiving 835 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 96
- Molecular Biology 656
- Oncology 186
- Cancer Research 97
- Cell Biology 81
Countries citing papers authored by James E. Mullally
This map shows the geographic impact of James E. Mullally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Mullally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Mullally more than expected).
Fields of papers citing papers by James E. Mullally
This network shows the impact of papers produced by James E. Mullally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Mullally. The network helps show where James E. Mullally may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Mullally, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 275 | |
| 2 | 2004 | 107 | |
| 3 | 2001 | 106 | |
| 4 | Survey of patients with granular, lattice, avellino, and Reis-Bücklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes. | 2001 | 89 |
| 5 | 2002 | 86 | |
| 6 | 2004 | 65 | |
| 7 | 2015 | 62 | |
| 8 | 2005 | 58 | |
| 9 | 2005 | 25 | |
| 10 | 2006 | 1 |
About James E. Mullally
James E. Mullally is a scholar working on Molecular Biology, Oncology, Genetics, Pharmacology and Molecular Medicine, having authored 10 papers that have together received 874 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Peptidase Inhibition and Analysis (4 papers), Cancer-related Molecular Pathways (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Glycosylation and Glycoproteins Research (2 papers), Inflammatory mediators and NSAID effects (1 paper), Connective tissue disorders research (1 paper) and Curcumin's Biomedical Applications (1 paper). The work is most often cited by research in Molecular Medicine (96 citations), Molecular Biology (656 citations), Oncology (186 citations), Cancer Research (97 citations) and Cell Biology (81 citations). James E. Mullally has collaborated with scholars based in United States and France. Frequent co-authors include F.A. Fitzpatrick, F.A. Fitzpatrick, Keith D. Wilkinson, Kornelia Edes, Philip J. Moos, Francisca E. Reyes‐Turcu, Xiaodong Cheng, A. Héroux, J.R. Horton and Chris M. Ireland. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry, Molecular Pharmacology, Cell and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.